Literature DB >> 27807736

[Analgesic drugs during pregnancy].

S Hultzsch1, C Schaefer2.   

Abstract

Some important limitations must be taken into consideration for analgesic therapy during pregnancy. Paracetamol is the agent of choice for mild to moderate pain in any stage of pregnancy. Ibuprofen is the non-steroidal anti-inflammatory drug (NSAID) of choice; however, these substances are contraindicated after 28 weeks of gestation due to the increasing risk of premature closure of the ductus arteriosus and impairment of fetal kidney function. Even opioids can be used for severe pain but peripartum administration can lead to neonatal respiratory depression and adaptation disorders and long-term therapy up to the end of pregnancy can lead to neonatal withdrawal symptoms. Migraine can also be treated with sumatriptan. Antiepileptic drugs should not be taken during pregnancy as a teratogenic risk mostly cannot be excluded; however, well studied antidepressants, such as amitriptyline can be used for chronic pain with the appropriate indications.

Entities:  

Keywords:  Acute pain; Analgesics, opioid; Anti-inflammatory agents, non-steroidal; Chronic pain; Migraine

Mesh:

Substances:

Year:  2016        PMID: 27807736     DOI: 10.1007/s00482-016-0167-9

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  27 in total

1.  Delivery outcome after maternal use of drugs for migraine: a register study in Sweden.

Authors:  Bengt Källén; Emma Nilsson; Petra Otterblad Olausson
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

2.  Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders.

Authors:  Zeyan Liew; Beate Ritz; Cristina Rebordosa; Pei-Chen Lee; Jørn Olsen
Journal:  JAMA Pediatr       Date:  2014-04       Impact factor: 16.193

3.  NSAIDs and spontaneous abortions - true effect or an indication bias?

Authors:  Sharon Daniel; Gideon Koren; Eitan Lunenfeld; Amalia Levy
Journal:  Br J Clin Pharmacol       Date:  2015-06-03       Impact factor: 4.335

Review 4.  First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.

Authors:  Dorte Lassen; Zandra Nymand Ennis; Per Damkier
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-11-03       Impact factor: 4.080

Review 5.  Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?

Authors:  John J McCarthy
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-25

6.  Use of dipyrone during pregnancy and risk of Wilms' tumor. Brazilian Wilms' Tumor Study Group.

Authors:  C R Sharpe; E L Franco
Journal:  Epidemiology       Date:  1996-09       Impact factor: 4.822

Review 7.  Labour analgesia and the baby: good news is no news.

Authors:  Felicity Reynolds
Journal:  Int J Obstet Anesth       Date:  2010-12-13       Impact factor: 2.603

Review 8.  The effects of maternal labour analgesia on the fetus.

Authors:  Felicity Reynolds
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2009-12-11       Impact factor: 5.237

9.  Pethidine compared with meptazinol during labour. A prospective randomised double-blind study in 1100 patients.

Authors:  C E Morrison; D Dutton; H Howie; H Gilmour
Journal:  Anaesthesia       Date:  1987-01       Impact factor: 6.955

Review 10.  The use of psychotropic medication during pregnancy: how about the newborn?

Authors:  Noera Kieviet; Koert M Dolman; Adriaan Honig
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-28       Impact factor: 2.570

View more
  1 in total

Review 1.  All roads lead to inflammation: Is maternal immune activation a common culprit behind environmental factors impacting offspring neural control of breathing?

Authors:  Andrew O Knutson; Jyoti J Watters
Journal:  Respir Physiol Neurobiol       Date:  2019-12-23       Impact factor: 1.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.